Drug Profile
NBI 30775
Alternative Names: R 121919Latest Information Update: 02 Aug 2000
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Class
- Mechanism of Action Corticotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder